Benzinga | May 14, 2021 01:37PM EDT

Qualigen Therapeutics Q4 EPS $(0.13), Sales $1.90M

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.13) per share. The company reported $1.90 million in sales this quarter.